Search

everythinglearnresearchcommunity

for

Search:↓

Chemotherapy can cause skin problems like hair loss, mouth sores, and skin darkening, and recognizing these can affect treatment decisions.

The document concludes that more research is needed to better understand and treat primary cicatricial alopecias, and suggests a possible reclassification based on molecular pathways.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Microneedles improve drug delivery in various body parts, are safe and painless, and show promise in cosmetology, vaccination, insulin delivery, and other medical applications.

Keratose, derived from human hair, is a non-toxic biomaterial good for tissue regeneration and integrates well with body tissues.

Stem cell therapy, particularly using certain types of cells, shows promise for treating hair loss by stimulating hair growth and development, but more extensive trials are needed to confirm these findings.

Exosomes could potentially enhance tissue repair and regeneration with lower rejection risk and easier production than live cell therapies.

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Restoring hair bulb immune privilege is crucial for managing alopecia areata.

Conditioned media from mesenchymal stem cell cultures could be a more effective alternative for regenerative therapies, but more research is needed.

The document concludes that early diagnosis and treatment of Congenital Adrenal Hyperplasia are crucial for preventing serious health issues and improving patient outcomes.

Tissue-resident memory T cells can protect against infections and cancer but may also contribute to autoimmune diseases.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Nanocarrier-loaded gels improve drug delivery for cancer, skin conditions, and hair loss.

Skin grafts are effective for chronic leg ulcers, especially autologous split-thickness grafts for venous ulcers, but more data is needed for diabetic ulcers.

Brain hormones significantly affect hair color and could potentially be used to prevent or reverse grey hair.

New methods to improve the healing abilities of mesenchymal stem cells for disease treatment are promising but need more research.

Botulinum toxin shows promise for various skin conditions but requires more research for confirmation and standardized use.

The document concludes that while there are promising methods to control CRISPR/Cas9 gene editing, more research is needed to overcome challenges related to safety and effectiveness for clinical use.

Thyroid function affects skin health, with a complex interaction between the two.

Changes in skin microbes play a role in some skin diseases and could lead to new treatments.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

The review suggests thorough evaluation and genetic testing for proper diagnosis and treatment of Chrousos syndrome.

Plasmacytoid dendritic cells are a key factor in causing hair loss in alopecia areata and could help differentiate it from other hair loss conditions.

Advancements in creating skin grafts with biomaterials and stem cells are promising, but more research is needed for clinical application.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Epidermal keratinocytes start wound healing and inflammation after schistosome infection.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.